London, United Kingdom

Nicola Anne Burgess


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Edmonton, GB (2000)
  • London, GB (2000 - 2001)

Company Filing History:


Years Active: 2000-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Nicola Anne Burgess: Innovator in Polypeptide Research

Introduction

Nicola Anne Burgess is a prominent inventor based in London, GB. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and polynucleotides. With a total of 4 patents to her name, her work has implications for both therapeutic and diagnostic applications.

Latest Patents

Among her latest patents, Nicola has disclosed compounds related to METPRO02 polypeptides and polynucleotides. These patents detail methods for producing such polypeptides through recombinant techniques. Additionally, she has outlined methods for utilizing METPRO02 polypeptides and polynucleotides in therapy, as well as diagnostic assays for their application. Another significant patent involves HE2NW40 polypeptides and polynucleotides, which also includes methods for their production and therapeutic use.

Career Highlights

Nicola Anne Burgess is currently associated with SmithKline Beecham Corporation, where she continues her innovative research. Her work has been instrumental in advancing the understanding and application of polypeptides in medical science.

Collaborations

Throughout her career, Nicola has collaborated with notable colleagues, including Christopher Donald Southan and Helen Elizabeth Clinkenbeard. These partnerships have further enriched her research and contributed to her success in the field.

Conclusion

Nicola Anne Burgess stands out as a leading inventor in the realm of biotechnology, with her patents paving the way for advancements in therapeutic and diagnostic methods. Her contributions are vital to the ongoing evolution of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…